SCB
ABBV icon

Saudi Central Bank’s AbbVie ABBV Stock Holding History

Saudi Central Bank’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.2M Buy
123,814
+58,578
+90% +$12.6M 0.41% 51
2026
Q1 		$14.2M Buy
+65,236
New +$14.5M 0.3% 56
2025
Q2 		– Sell
-695
Closed -$146K – 56
2025
Q1 		$146K Buy
+695
New +$135K 0.77% 22

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Saudi Central Bank's ABBV Position: Q2 2026 in Review

Saudi Central Bank increased its AbbVie (ABBV) stake by 90% in Q2 2026, buying an estimated $12.6M and bringing the position to 123,814 shares worth $31.2M. The position accounts for 0.41% of the portfolio, ranked #51.

Saudi Central Bank first reported a position in ABBV in Q1 2025 and has held it in 3 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Saudi Central Bank held 123,814 shares of AbbVie worth $31.2M as of Q2 2026.
  • Saudi Central Bank bought 58,578 AbbVie shares in Q2 2026, an estimated $12.6M.
  • AbbVie made up 0.41% of Saudi Central Bank's portfolio in Q2 2026, its #51 holding.
  • Saudi Central Bank first reported a position in AbbVie in Q1 2025 and has held it in 3 quarters since.
  • 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.